Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat
Open Access
- 21 September 2010
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 35 (5) , 658-665
Abstract
To investigate the anti-obesity effect of the adipokine zinc-α2-glycoprotein (ZAG) in rats and the mechanism of this effect. Mature male Wistar rats (540±83 g) were administered human recombinant ZAG (50 μg per 100 g body weight given intravenously daily) for 10 days, while control animals received an equal volume of phosphate-buffered saline (PBS). Animals treated with ZAG showed a progressive decrease in body weight, without a decrease in food and water intake, but with a 0.4 °C rise in body temperature. Body composition analysis showed loss of adipose tissue, but an increase in lean body mass. The loss of fat was due to an increase in lipolysis as shown by a 50% elevation of plasma glycerol, accompanied by increased utilization of non-esterified fatty acids, as evidenced by the 55% decrease in plasma levels. Plasma levels of glucose and triglycerides were also reduced by 36–37% and there was increased expression of the glucose transporter 4 in both skeletal muscle and adipose tissue. Expression of the lipolytic enzymes adipose triglyceride lipase and hormone-sensitive lipase in the white adipose tissue (WAT) were increased twofold after ZAG administration. There was almost a twofold increased expression of uncoupling proteins 1 and 3 in brown adipose tissue and WAT, which would contribute to increased substrate utilization. Administration of ZAG increased ZAG expression twofold in the gastrocnemius muscle, BAT and WAT, which was probably necessary for its biological effect. These results show that ZAG produces increased lipid mobilization and utilization in the rat.Keywords
This publication has 32 references indexed in Scilit:
- The adipokine zinc‐α2‐glycoprotein (ZAG) is downregulated with fat mass expansion in obesityClinical Endocrinology, 2010
- Antidiabetic Properties of Zinc-α2-Glycoprotein in ob/ob MiceEndocrinology, 2009
- Skeletal Muscle Atrophy, a Link between Depression of Protein Synthesis and Increase in DegradationJournal of Biological Chemistry, 2007
- Lipolysis is altered in MHC class I zinc‐α2‐glycoprotein deficient miceFEBS Letters, 2007
- A Unique Role of Monocyte Chemoattractant Protein 1 among Chemokines in Adipose Tissue of Obese SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2005
- The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexiaBritish Journal of Cancer, 2005
- Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexiaProceedings of the National Academy of Sciences, 2004
- Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoproteinBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2004
- Identification of Epistatic Interaction Involved in Obesity Using the KK/Ta Mouse as a Type 2 Diabetes ModelDiabetes, 2003
- Complete amino acid sequence of human plasma Zn-alpha 2-glycoprotein and its homology to histocompatibility antigens.Proceedings of the National Academy of Sciences, 1988